Clinical trial
Feasibility Protocol for Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis
NCT07282002 is registered in ClinicalTrials.gov with Angiodynamics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Protocol for Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis
- Lead sponsor
- Angiodynamics, Inc.
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- April 30, 2026
- Completion date
- March 31, 2027
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
infective endocarditis (ie)